chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Culture throat, Dizziness, Nausea, Vertigo
Clinical narrative: Vertigo started 3/20/2021.; I was extremely dizzy. This is still ongoing; I was extremely nauseated. This is still ongoing; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6208), via an unspecified route of administration in the left arm on 15Mar2021 at 09:15 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included RA (rheumatoid arthritis) and hypothyroidism. Concomitant medications included unspecified medications within 2 weeks of vaccination. The patient was allergic to clindamycin, augmentin and adhesive. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not been diagnosed with COVID-19, prior to the vaccination. On 20Mar2021, at 08:00, the patient had experienced vertigo, was extremely dizzy and nauseated. Therapeutic measures were taken as the result of adverse events, which included treatment with bonine, zofran, ativan and medrol dose pack. The patient underwent lab tests and procedures which included throat swab on 08Sep2020 and was tested negative. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as the result of adverse events. The clinical outcome of vertigo, dizziness and nausea was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: contracted Covid; This is a spontaneous report from a contactable consumer or other non hcp. An 83-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for Injection, Lot Number and Expiration date was not reported), via an unspecified route of administration on 20Jan2021(at the age of 83-year-old) as single dose for covid-19 immunization. The patient medical history was not reported. The patient concomitant medications were not reported. On 23Jan2021 she contracted Covid from the skilled nursing facility she was in. She received Covid antibody therapy on 24Jan2021. Reporter wants to know when she can get the second dose of the vaccine. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 23Jan2021. Outcome of event was unknown.  Information on the lot/batch number has been requested.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Chills; slight headache; tired; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: ER8732) via an unspecified route of administration in the right arm on 29Mar2021 at 13:15 as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. The concomitant medications included omeprazole (MANUFACTURER UNKNOWN) of 40 mg and multivitamins for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6206) via an unspecified route of administration in the right arm on 08Mar2021 at 13:15 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 30Mar2021 at 06:00, the patient experienced chills, slight headache and tiredness. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, headache and tiredness was resolved on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Flushing, Lymphadenopathy, Nasal discomfort, Neck pain
Clinical narrative: Red flushing cheeks at time of shot; swollen glands in neck; extreme pain in front of neck; shortness of breath/painful breathing; burning lips; burning nose; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in left arm on 06Mar2021 at 00:00 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune diseases and allergies to sulfa drugs. The patient took unspecified medication within two weeks.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Mar2021, the patient experienced red flushing cheeks at time of shot, swollen glands in neck, extreme pain in front of neck, shortness of breath, painful breathing, burning nose and lips. The adverse events resulted in a doctor or other healthcare professional office or clinic visit, and an emergency room or a department or urgent care. Therapeutic measures were taken as a result of the reported events and included treatment with BENADRYL and ant-inflammatory medications. The clinical outcome of the event red flushing cheeks at time of shot, swollen glands in neck, extreme pain in front of neck, shortness of breath, painful breathing, burning nose and lips was recovering.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Oral discomfort
Clinical narrative: Red flushing cheeks at time of shot; swollen glands in neck; extreme pain in front of neck; shortness of breath/painful breathing; burning lips; burning nose; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in left arm on 06Mar2021 at 00:00 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune diseases and allergies to sulfa drugs. The patient took unspecified medication within two weeks.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Mar2021, the patient experienced red flushing cheeks at time of shot, swollen glands in neck, extreme pain in front of neck, shortness of breath, painful breathing, burning nose and lips. The adverse events resulted in a doctor or other healthcare professional office or clinic visit, and an emergency room or a department or urgent care. Therapeutic measures were taken as a result of the reported events and included treatment with BENADRYL and ant-inflammatory medications. The clinical outcome of the event red flushing cheeks at time of shot, swollen glands in neck, extreme pain in front of neck, shortness of breath, painful breathing, burning nose and lips was recovering.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Erythema, Fatigue, Pain in extremity, Pruritus
Clinical narrative: Peeling; Small swollen area; Itching; Developed redarea; Fever; Fatigue; Arm soreness; This is a spontaneous report from a contactable consumer, the patient.  A 74-year-old non-pregnant female patient received second dose of BNTI62b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 23Feb2021 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimotos thyroiditis and osteoporosis. The patient had allergy to lactose intolerance. The patient previously received chlorthalidone (MANUFACTURER UNKNOWN) for unspecified indication and experienced drug allergy. The patient had received other unspecified medications in two weeks of vaccination. The patient previously received first dose of BNTI62b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9265) via an unspecified route of administration in the left arm on 30Jan2021 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 24Feb2021, the patient experienced arm soreness several days and fatigue first four days. On 24Feb2021, (next day) the patient experienced fever 99.4 degrees. On 25Feb2021, (second day) the patient developed red area. On 26Feb2021, (third day) the patient experienced itching which lasted a week and small swollen area on the same day. On 27Feb2021, (fifth day) small peeling began which lasted about four days. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures taken for the adverse event included hydrocortisone cream and ZYRTREC which did not help. The clinical outcome of fatigue was recovered on 28Feb2021. The clinical outcome of the events arm soreness, swelling and fever were recovered on an unknown date. The clinical outcome of red, itching and peeling were recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Skin exfoliation, Swelling
Clinical narrative: Peeling; Small swollen area; Itching; Developed redarea; Fever; Fatigue; Arm soreness; This is a spontaneous report from a contactable consumer, the patient.  A 74-year-old non-pregnant female patient received second dose of BNTI62b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 23Feb2021 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimotos thyroiditis and osteoporosis. The patient had allergy to lactose intolerance. The patient previously received chlorthalidone (MANUFACTURER UNKNOWN) for unspecified indication and experienced drug allergy. The patient had received other unspecified medications in two weeks of vaccination. The patient previously received first dose of BNTI62b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9265) via an unspecified route of administration in the left arm on 30Jan2021 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 24Feb2021, the patient experienced arm soreness several days and fatigue first four days. On 24Feb2021, (next day) the patient experienced fever 99.4 degrees. On 25Feb2021, (second day) the patient developed red area. On 26Feb2021, (third day) the patient experienced itching which lasted a week and small swollen area on the same day. On 27Feb2021, (fifth day) small peeling began which lasted about four days. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures taken for the adverse event included hydrocortisone cream and ZYRTREC which did not help. The clinical outcome of fatigue was recovered on 28Feb2021. The clinical outcome of the events arm soreness, swelling and fever were recovered on an unknown date. The clinical outcome of red, itching and peeling were recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eye pain, Fatigue, Headache, Tinnitus
Clinical narrative: Headache; Chills; Sore eyes; Fatigue; Tinnitus in my right ear; This is a spontaneous report from a contactable consumer, patient. A 56-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration in the left arm on 26Mar2021 at 08:15 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine. Concomitant medications included vitamins (MANUFACTURER UNKNOWN), temazepam (MANUFACTURER UNKNOWN), hormonal replacement therapy (MANUFACTURER UNKNOWN), non-steroidal anti-inflammatory (MANUFACTURER UNKNOWN); all for unknown indications from an unknown date. The patient previously received naproxen (MANUFACTURER UNKNOWN) on unknown date for unspecified indications and experienced drug allergy and sulfa drugs on unknown date for unspecified indication and experienced sulfonamide allergy. Prior to vaccination, the patient was not diagnosed with Covid-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Mar2021 at 20:00, about 12 hours after the shot, the patient experienced headache, chills, sore eyes, fatigue, and tinnitus in the right ear which all lasted about 36 hours. Then patient was left with just the tinnitus for about 24 hours. Then she woke with the headache, sore eyes, and continued tinnitus. It's Tuesday evening, and she received the shot last Friday morning. she still had these symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events headache, chills, sore eyes, fatigue, and tinnitus were not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: Fatigue-slept most of the day; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number:ER8772) via an unspecified route of administration in the left arm on 28Mar2021 at 11.45 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history included early heart disease. The patient had no allergies to medications, food or other products. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 07Mar2021 at 16:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On28Mar2021 at 12.00, the patient experienced fatigue and body ache. The patient slept most of the day after and took a 3hr nap on the second day. The patient experienced body aches off and on lasting for 3days. Therapeutic measure was taken as a result of the events which included treatment with tylenol. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event body ache and fatigue was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Fatigue, Headache
Clinical narrative: Fatigue and headache in first 24 hours followed by a tightness in my chest and shortness of breath; Fatigue and headache in first 24 hours followed by a tightness in my chest and shortness of breath; Fatigue and headache in first 24 hours followed by a tightness in my chest and shortness of breath; Fatigue and headache in first 24 hours followed by a tightness in my chest and shortness of breath; This is a spontaneous report from a contactable consumer (patient). A 50-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCIN), via an unspecified route of administration, administered in left arm on 17Mar2021 at 15:45 (at 50 years old) as Single dose for COVID-19 immunization.  There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. There were no medical history and concomitant medications. The patient had no known allergies. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. The patient experienced fatigue and headache in first 24 hours followed by a tightness in my chest and shortness of breath which continued from 19Mar2021 to 30Mar2021. Start date of the events was reported as on 17Mar2021 at 18:00. No treatment received for the events. Outcome of the events was not recovered.  Information about Lot/Batch number was requested.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Lip disorder, Lip swelling, Paraesthesia oral
Clinical narrative: Lips felt tingly 2 hours after injection; Swelling occurred on  two of lip injection sites; Right bottom lip has a "bump" as wellas top right lip; This is a spontaneous report from a contactable consumer, the patient. A 48-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8730) via an unspecified route of administration in the arm left on 30Mar2021 at 15:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included brain aneurysm. The patient was allergic to fentanyl, Versed and bees. The patient's past therapy included Juvederm injections in Aug2020. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Mar2021 at 18:30, the patient's right bottom lip had a bump as well as top right lip. The patient's lips felt tingly 2 hours after injection then swelling occurred on two of lip injection sites. The bumps were very small. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tingling lips, swollen lips and bumps lip was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dysstasia, Vomiting
Clinical narrative: Dizziness; not able to stand; vomiting; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er2613) via an unspecified route of administration in the left arm on 27MAr2021 at 16:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient previously had pollen allergy. The patient did not receive any concomitant medication. The patient previously received the first dose of BNT162b2 (PFIZER COVID-19 mRNA VACCINE BIONTECH, Lot number: en6205) via an unspecified route of administration in the left arm on 06Mar2021 at 04:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, the patient experienced dizziness, vomiting, and difficulty in standing 6 hours after vaccination (at 22:00). The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of the events dizziness, vomiting, and difficulty in standing was recovered on an unknown date at the time of report.    No follow-up attempts are needed. No further information is expected.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Panic attack, Tinnitus
Clinical narrative: This is a spontaneous report received from a contactable consumer, the patient. An 83-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via unspecified route of administration in the left arm on 16Feb2021 at 09:30 hours (at the age of 83-years- old) as a single dose for COVID-19 immunisation. Medical history included Macular degeneration (mild), glaucoma, epstein barr, vestibular neuritis, benign paroxysmal positional vertigo(BPPV), claustrophobia from unspecified date. The patient was allergic to penicillin, epinephrine, procaine (NOVOCAINE), narcotic related codeine, erythromycin and allergic to shrimp. Concomitant medication included rosuvastatin (MANUFACTURER UNKNOWN), tafluprost (ZIOPTAN), ascorbic acid; tocopheryl acetate; zinc; xantofyl; zeanthin (AREDS), D3(MANUFACTURER UNKNOWN) and sambucus nigra (ELDERBERRY) from an unspecified date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9262) via an unspecified route of administration in the left arm on 26Jan2021 at 08:30 hours (at the age of 83-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. On 13Mar2021, at 01:30 hours, the patient awakened at middle of the night with sudden loud tinnitus. Panic attack was experienced, had claustrophobia anyway so exacerbated the issue. The event resulted in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient received anti- anxiety prescription as treatment for the events. The patient went to physical therapy facility for balance and ear crystal treatment and it was continuing at the time of this report. The patient was under evaluation. The clinical outcome of the event panic attack and tinnitus was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: First vaccine 2/18/21, raised rashinner arms, arm pits, body sides,stomach inner thighs. After seconddose moved to upper thighs and back; This is a spontaneous report from a contactable consumer, the patient. A 78-year-old male patient received  first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 18Feb2021 and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6199) via an unspecified route of administration in the left arm on 11Mar2021 (at the age of 78-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis. The patient had no known allergies. Concomitant medications included pravastatin (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN) for unknown indications and duration. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced rash on the inner arms, arm pits, body sides, stomach inner thighs after receiving the first dose. On 23Feb2021, the patient experienced rash on the upper thighs and back. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received first steroid shot and on 29Mar2021, the patient had taken prednisone p (MANUFACTURER UNKNOWN) as a treatment for the adverse event.  The clinical outcome of the events generalized rash was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Sensitive skin
Clinical narrative: This is a spontaneous report from a non-contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via unspecified route of administration in the left arm on 29Mar2021 at 16:30 (at the age of 22-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history reported. Concomitant medications included escitalopram 10 mg (MANUFACTURER UNKNOWN) and ethinylestradiol, norgestimate (TRI FEMYNOR); both started on an unknown date for unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via unspecified route of administration in the left arm on 09Mar2021 at 16:30 (at the age of 22-year-old), as a single dose for COVID-19 immunisation. It was unknown if the patient had any known allergies to food, medications or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Mar2021 at 12:00, the patient experienced severe muscle aches, hypersensitive skin (washing hands was uncomfortable and anything bumped into was hurt 100 times worse), headaches, chills and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any therapeutic treatment for muscle aches, hypersensitive skin, headaches, chills and fatigue. The clinical outcomes of the events severe muscle aches, hypersensitive skin, headaches, chills and fatigue were not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Discomfort, Illness, Insomnia
Clinical narrative: 12 hours after receiving my second dose I became very ill.; skin hurt; I became to shiver uncontrollably and could not get warm enough; I developed a fever of 101.4; My muscles ache. Instead of feeling "sick"this was more painful than "ill".; it is difficult tosleep.; I'm in somuch discomfort; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 29Mar2021 at 12:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, sleep apnea and pre-diabetes. Concomitant medications included propranolol 120 mg (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN) and armodafinil (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Mar2021 at 15:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation and morphine on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Mar2021 at 00:30 after 12 hours of second dose, the patient experienced illness, skin hurt, shivered uncontrollably and was not getting warmed enough, fever - 101.4 (unspecified unit), muscle ache, hurt to move, discomfort and difficulty sleeping. The patient did not receive any treatment for the event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of illness, skin pain, shivers, fever, muscle ache, sleep difficult and discomfort were not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain of skin, Pyrexia
Clinical narrative: 12 hours after receiving my second dose I became very ill.; skin hurt; I became to shiver uncontrollably and could not get warm enough; I developed a fever of 101.4; My muscles ache. Instead of feeling "sick"this was more painful than "ill".; it is difficult tosleep.; I'm in somuch discomfort; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 29Mar2021 at 12:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, sleep apnea and pre-diabetes. Concomitant medications included propranolol 120 mg (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN) and armodafinil (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Mar2021 at 15:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation and morphine on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Mar2021 at 00:30 after 12 hours of second dose, the patient experienced illness, skin hurt, shivered uncontrollably and was not getting warmed enough, fever - 101.4 (unspecified unit), muscle ache, hurt to move, discomfort and difficulty sleeping. The patient did not receive any treatment for the event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of illness, skin pain, shivers, fever, muscle ache, sleep difficult and discomfort were not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Nausea, Pain
Clinical narrative: Body aches; Chills; Fever; Nausea; Arm soreness; Fatigue; Weakness; Near-fainting; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: UNKNOWN) via unspecified route of administration in the left arm on 26Mar2021 at 08:45 (age at vaccination 56-year-old) as a single dose for COVID-19 immunisation . Medical history included hypogammaglobulinemia. The patient reported allergies to sulfa, fluoroquinolones, ambien, vicodin, nickel. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN), vitamin C (MANUFACTURER UNKNOWN), probiotic (MANUFACTURER UNKNOWN), famotidine (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19 on unspecified date. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 26Mar2021 at 08:45, the patient experienced body aches, chills, fever, nausea, arm soreness, fatigue, weakness and near-fainting. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic treatment were taken for the reported events. The clinical outcome of the events of body aches, chills, fever, nausea, arm soreness, fatigue, weakness and near-fainting were resolved with lasting effects.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Presyncope, Pyrexia
Clinical narrative: Body aches; Chills; Fever; Nausea; Arm soreness; Fatigue; Weakness; Near-fainting; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: UNKNOWN) via unspecified route of administration in the left arm on 26Mar2021 at 08:45 (age at vaccination 56-year-old) as a single dose for COVID-19 immunisation . Medical history included hypogammaglobulinemia. The patient reported allergies to sulfa, fluoroquinolones, ambien, vicodin, nickel. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN), vitamin C (MANUFACTURER UNKNOWN), probiotic (MANUFACTURER UNKNOWN), famotidine (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19 on unspecified date. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 26Mar2021 at 08:45, the patient experienced body aches, chills, fever, nausea, arm soreness, fatigue, weakness and near-fainting. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic treatment were taken for the reported events. The clinical outcome of the events of body aches, chills, fever, nausea, arm soreness, fatigue, weakness and near-fainting were resolved with lasting effects.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: For last several months knee pain had beensignificant & had recent knee injection,which provided no relief. As of yesterday morning, 3/29 I notice the joint pain, weakness and swellingthroughout body is gone.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 26Mar2021 at 14:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis and multiple allergies. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included vitamin b nos (VITAMIN B), colecalciferol (VIT D3), ascorbic acid (VIT C) and probiotics nos (MANUFACTURER UNKNOWN), all taken for unknown indication since an unspecified date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine) via an unspecified route of administration in the right arm on 05Mar2021 at 02:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient reported that, this was not adverse and was actually positive, but thought it should also be reported and don't see a place. From 09:00 to 16:00 the patient had fairly high pain level, largely concentrated in joints. The patient had suffered from trigger finger, ankle & wrist arthritis, meniscus prior meniscus surgeries for years. For last several months the patient had knee pain which had been significant & had recent knee injection, which provided no relief. As of previous day morning, on 29Mar2021, the patient noticed that the joint pain, weakness and swelling throughout body was gone. The patient reported that this could be of short term, but for now that was amazing. The patient's systemic joint issues began after a deep finger cut years ago that became inflamed. The patient had "no idea if vaccine killed another virus or what the hell was going on but, "yay".  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Taste disorder
Clinical narrative: Terrible taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 10:00(at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included lupus SLE (systemic lupus erythematosus), hypothyroidism, narcolepsy and penicillin allergy. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), meloxicam (MANUFACTURER UNKNOWN), hydroxychloroquine sulfate(PLAQUENIL) and armodafinil (MANUFACTURER UNKNOWN), all from unknown dates and for unknown indications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 27Mar2021 at 17:00, the patient experienced terrible taste. It was reported that the patient experienced terrible taste in mouth since a little while after the vaccine was given, vaccine administered around 10:00 and the taste developed later that day around 17:00. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event terrible taste was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Large swollen lymph node to the left of my left breast.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number EK8734) via unspecified route of administration in the left arm on 27Mar2021 at 10:00 (at the age 56-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity. The patient had no known allergies to medications, food and other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number EN6200) via unspecified route of administration in the left arm on 06Mar2021 at 10:00 (at the age 56-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 29Mar2021 at 20:00, the patient experienced large swollen lymph node to the left of left breast, was not quite under the arm and lymph node was painful. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of painful lymphadenopathy was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nasal congestion, Oropharyngeal pain
Clinical narrative: Sore throat; stuffy nose; tiredness; This is a spontaneous report from contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8735), via an unspecified route of administration in the left arm on 29Mar2021 at 16:15 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 30Mar2021 at 16:00, the patient experienced sore throat, stuffy nose and tiredness. The events resulted in doctor or other healthcare professional office or clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events sore throat, stuffy nose and tiredness were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: 2.5mm red circle around injection site; Swelling on shoulder; Swelling on shoulder along with pain; Tenderness of muscles surrounding shoulder; Fatigue; Headache; Chills; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 29Mar2021 at 13:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient was unknown about the allergies to medications, food, or other products. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), paracetamol (TYLENOL), buspirone (MANUFACTURER UNKNOWN), cannabidiol (CBD) (MANUFACTURER UNKNOWN) and nutrients NOS (ENSURE); all from unknown date for unknown indications. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Mar2021, the patient experienced 2.5mm red circle around injection site, swelling on shoulder, swelling on shoulder along with pain tenderness of muscles surrounding shoulder, severe fatigue, minor headaches and chills. The patient did not receive any treatment for the reported events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events 2.5mm red circle around injection site, swelling on shoulder, swelling on shoulder along with pain, tenderness of muscles surrounding shoulder, fatigue, headache and chills were not resolved at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Vaccination site erythema
Clinical narrative: 2.5mm red circle around injection site; Swelling on shoulder; Swelling on shoulder along with pain; Tenderness of muscles surrounding shoulder; Fatigue; Headache; Chills; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 29Mar2021 at 13:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient was unknown about the allergies to medications, food, or other products. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), paracetamol (TYLENOL), buspirone (MANUFACTURER UNKNOWN), cannabidiol (CBD) (MANUFACTURER UNKNOWN) and nutrients NOS (ENSURE); all from unknown date for unknown indications. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Mar2021, the patient experienced 2.5mm red circle around injection site, swelling on shoulder, swelling on shoulder along with pain tenderness of muscles surrounding shoulder, severe fatigue, minor headaches and chills. The patient did not receive any treatment for the reported events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events 2.5mm red circle around injection site, swelling on shoulder, swelling on shoulder along with pain, tenderness of muscles surrounding shoulder, fatigue, headache and chills were not resolved at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site pain, Vaccination site swelling
Clinical narrative: Injection site was sore; Bruising at injection site; Injection site was also swollen; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732), via an unspecified route of administration in the left arm on 28Mar2021 at 13:15 (at the age of 52-years-old), as a single dose for COVID-19 immunisation. The patients medical history included allergies to penicillin. The patient did not take any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 07Mar2021 at 13:15 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021, the patient experienced bruising at injection site, injection site was swollen and injection site was sore. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events bruising at injection site, injection site was swollen and injection site was sore were recovering at the time of reporting.   No follow-up attempts are needed. No further information is expected.